HLA traits linked to development of head and neck squamous cell carcinoma affect the progression-free survival of patients. (June 2017)

• Record Type: Journal Article
• Authors: Wichmann, Gunnar; Herchenhahn, Cindy; Boehm, Andreas; Mozet, Christian; Hofer, Mathias; Fischer, Milos; Kolb, Marlen; Dietz, Andreas
• Is Part Of: Oral oncology. Volume 69(2017)
• Page Start: 115
• Page End: 127
• Publication Date: 2017-06
• Subjects: Head and neck squamous cell carcinoma (HNSCC) -- Head and neck cancer epidemiology -- Human leukocyte Antigen (HLA) -- HLA haplotype -- Progression-free survival (PFS) -- Genetic susceptibility -- Cancer epidemiology -- T-cell response -- Tumor-associated antigen (TAA) -- Neoantigen; Mouth -- Cancer -- Periodicals; Mouth -- Tumors -- Periodicals; Mouth Diseases -- Periodicals; Mouth Neoplasms -- Periodicals; Bouche -- Cancer -- Périodiques; Bouche -- Tumeurs -- Périodiques; Tumeurs -- Périodiques; Electronic journals; 616.9943105
• DOI: 10.1016/j.oraloncology.2017.04.017
• Languages: English
• ISSNs: 1368-8375

Abstract

Highlights: Except HLA-B ( p < 0.05) HNSCC patients have unaltered HLA allele frequencies. PFS of HNSCC patients with either homozygous HLA-C or DRB4 is decreased ( p < 0.05). Multivariate analyses identify 10 HLA traits as independent risk factors for PFS. Altered HLA-B frequencies and uncommon HLA-B haplotypes are linked to reduced PFS. Considering HLA in HNSCC patient stratification for clinical trials is recommended. Abstract: Background: Personalized medicine and treatment stratification of patients with head and neck squamous cell carcinoma (HNSCC) today mostly ignore genetic heterogeneity in HNSCC but especially the patient's genetic background. We hypothesized that particular human leukocyte antigen (HLA) class I (HLA-A, B, Cw) and II proteins (DR, DQ) confer susceptibility for and influence development of HNSCC and may be prognostic factors for progression-free survival (PFS). Methods: 90 consecutive HNSCC patients of the prospective observational cohort study LIFE treated between 08/2010 and 05/2011 at the University Leipzig underwent low resolution typing of HLA-A, B, Cw, DR, and DQ. Antigen and haplotype frequencies were compared to those in German blood donors. Effects on PFS were analyzed using Kaplan-Meier curves and Cox models. Results: HNSCC patients had overall altered HLA-B frequencies ( P < 0.05); frequencies of B∗44 were lower, those of B∗13, B∗52, and B∗57 increased ( P < 0.05). Almost all other antigen frequencies showed no deviation. Homozygous HLA-Cw and DRB4 were frequent and associated with reduced PFS ( P < 0.05). Altered haplotype frequencies were common and particular haplotypes accompanied by differing PFS. B∗13/Cw∗06 carriers had poorest outcome ( P = 0.011). However, multivariate Cox proportional hazard models revealed 3 clinical covariates (localization oropharynx, loco-regional metastasis, and T4 category), HPV16-DNA positivity, and 10 HLA traits as independent predictors for PFS. Conclusions: The relevance of the genetic background of HNSCC patients calls for future research to clarify the role of HLA traits in HNSCC and if PFS depends on HLA.